XML 97 R87.htm IDEA: XBRL DOCUMENT v3.21.2
BUSINESS COMBINATIONS AND ASSET ACQUISITIONS - Asset Acquisitions Textual (Details) - USD ($)
$ in Thousands, shares in Millions
1 Months Ended
Jun. 23, 2021
Jan. 11, 2021
Jan. 31, 2021
May 03, 2021
PFS Genomics        
Business Acquisition [Line Items]        
Percent of equity acquired 10.00%     90.00%
Total purchase price $ 33,569      
Equity interest in acquiree after subsequent acquisition 100.00%      
TARDIS Technology        
Business Acquisition [Line Items]        
Asset acquisition, consideration transferred   $ 52,300    
Payments to acquire productive assets   $ 25,000    
Payments to acquire productive assets (in shares)   0.2    
Stock issued to acquire productive assets, value   $ 27,300    
Sales Milestone Range One | TARDIS Technology        
Business Acquisition [Line Items]        
Payments contingent on milestones   10,000    
Collaborative arrangement sales milestone amount     $ 100,000  
Sales Milestone Range Two | TARDIS Technology        
Business Acquisition [Line Items]        
Payments contingent on milestones   $ 35,000    
Collaborative arrangement sales milestone amount     $ 250,000